In vitro, mTOR inhibition significantly promotes the proliferation of basal cells derived from neonatal tracheal aspirate, which may constitute a critical model system for studying late fetal lung development and perinatal lung diseases, including BPD [36]. Here, MTOR is linked to bronchopulmonary dysplasia.